348
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China

, , , , , , , , & show all
Pages 721-731 | Published online: 29 Mar 2019

References

  • ShahNSWrightABaiGHWorldwide emergence of extensively drug-resistant tuberculosisEmerg Infect Dis200713338038717552090
  • World Health OrganizationWHO global tuberculosis report 2017GenevaWorld Health Organization2017
  • BruningJBMurilloACChaconOBarlettaRGSacchettiniJCStructure of the Mycobacterium tuberculosis D-alanine:D-alanine ligase, a target of the antituberculosis drug D-cycloserineAntimicrob Agents Chemother201155129130120956591
  • EpsteinIGNairKGBoydLJCycloserine, a new antibiotic, in the treatment of human pulmonary tuberculosis: a preliminary reportAntibiotic Med Clin Ther1955128093
  • SomnerARBraceAAEthionamide, pyrazinamide and cycloserine used successfully in the treatment of chronic pulmonary tuberculosisTubercle196243434536013978199
  • CohenACPyridoxine in the prevention and treatment of convulsions and neurotoxicity due to cycloserineAnn N Y Acad Sci196916613463495262029
  • Crofton SirJChauletPMaherDGuidelines for the management of drug-resistant tuberculosisTrans R Soc Trop Med Hyg19979115179093617
  • World Health OrganizationGuidelines for the Programmatic Management of Drug-Resistant Tuberculosis Guidelines for the Programmatic Management of Drug-Resistant TuberculosisGenevaWorld Health Organization200812185
  • World Health OrganizationRapid Communication: Key Changes to Treatment of Multidrug-and Rifampicin-Resistant Tuberculosis (MDR/RR-TB)GenevaWorld Health Organization2018
  • WangXFuQLiZDrug-resistant tuberculosis in Zhejiang Province, China, 1999–2008Emerg Infect Dis201218349649822377167
  • ZhangLMengQChenSTreatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009–2013Clin Microbiol Infect201824438138828712668
  • SunFLiYChenYIntroducing Molecular Testing of Pyrazinamide Susceptibility Improves MDR-TB Treatment Outcomes: A Prospective Cohort StudyEur Respir J20181801770
  • Eurosurveillance editorial teamRevised definitions and reporting framework for tuberculosisEuro Surveill201318162045523611033
  • MiglioriGBEkerBRichardsonMDA retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosisEur Respir J200934238739319282348
  • World Health OrganizationPolicy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugsGenevaWorld Health Organization2008120
  • FerlazzoGMohrELaxmeshwarCEarly safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort studyLancet Infect Dis201818553654429452942
  • DiaconAHPymAGrobuschMPMultidrug-resistant tuberculosis and culture conversion with bedaquilineN Engl J Med2014371872373225140958
  • CamineroJAPiubelloAScardigliAMiglioriGBBedaquiline: how better to use itEur Respir J2017505e1701670
  • PrasadRVermaSKSahaiSKumarSJainAEfficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patientsIndian J Chest Dis Allied Sci20064818318618610675
  • TahaoğluKTörünTSevimTThe treatment of multidrug-resistant tuberculosis in TurkeyN Engl J Med2001345317017411463011
  • MasjediMRTabarsiPChitsazEOutcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002–2006Int J Tuberc Lung Dis20081275075518544199
  • MitnickCDShinSSSeungKJComprehensive treatment of extensively drug-resistant tuberculosisN Engl J Med2008359656357418687637
  • CegielskiJPDaltonTYaguiMExtensive drug resistance acquired during treatment of multidrug-resistant tuberculosisClin Infect Dis20145981049106325057101
  • YuXZengXShiWValidation of cycloserine efficacy in treatment of multidrug-resistant and extensively drug-resistant tuberculosis in Beijing, ChinaAntimicrob Agents Chemother2018623e018241729311073
  • HungWYYuMCChiangYCSerum concentrations of cycloserine and outcome of multidrug-resistant tuberculosis in Northern TaiwanInt J Tuberc Lung Dis201418560160624903799
  • HwangTJWaresDFJafarovAJakubowiakWNunnPKeshavjeeSSafety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysisInt J Tuberc Lung Dis201317101257126623735593
  • SchadeSPaulusWD-cycloserine in neuropsychiatric diseases: a systematic reviewInt J Neuropsychopharmacol2016194pyv10226364274
  • HolmesCXMartinGEFetterhoffKIThe role of the cycloserine (seromycin) blood level in the treatment of pulmonary tuberculosis and the prevention and control of cycloserine (seromycin) toxicityDis Chest195936659159314402775
  • SharmaBHandaRNagpalKPrakashSGuptaPKAgrawalRCycloserine-induced psychosis in a young female with drug-resistant tuberculosisGen Hosp Psychiatry201436451e3e424120022